Long Covid Is an Elusive Target for Big Pharma
This is the second column in a three-part Heard on the Street series on long Covid.
The drug industry developed Covid-19 vaccines and treatments at breakneck speed, saving millions of lives in the process. Yet treatments for the post-viral illness known as long Covid, which is afflicting millions, are nowhere close to being developed.
More Stories
NASA scrubs launch of new moon rocket after engine problem
By MARCIA DUNN CAPE CANAVERAL, Fla. (AP) — NASA called off the launch of its mighty new moon rocket on...
Gas-powered muscle cars drive into the sunset, turn electric
PONTIAC, Mich. — Thundering gas-powered muscle cars, for decades a fixture of American culture, will be closing in on their...
Turkey’s Central Bank Cuts Rates in Surprise Decision
ISTANBUL—Turkey’s central bank unexpectedly cut key interest rates for the first time in eight months on Thursday, resuming an unconventional...
Stock Futures Edge Up as Investors Mull Jobs Data, Fed Minutes
U.S. stock futures nudged up as jobless claims declined and investors digested meeting minutes from the Federal Reserve that showed...
Wait, When Did Everyone Start Using Apple Pay?
Patience isn’t the most popular virtue in Silicon Valley, where companies aspire to move fast and break things, the motto...
U.S. Home-Sales Report for July Comes as Housing Market Cools
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber...